MeSH tree: C10.114
A new PET imaging approach that measures synaptic density in the spinal cord provides a quantitative way to assess the brain's functional wiring in patients with multiple sclerosis. With this personalized information, physicians ...
Jun 2, 2026
0
2
A new study has revealed a group of blood proteins that are altered in people who go on to develop multiple sclerosis (MS), in some cases more than a decade before diagnosis. The findings offer hope that a simple blood test ...
May 30, 2026
0
6
A new study published in Nature Communications shows that human glial progenitor cells are a promising and safe cell product for transplantation. The research also defines the transcriptional and epigenetic signatures of ...
May 29, 2026
0
4
A major international Phase III clinical trial, led by Queen Mary University of London, has found that ocrelizumab—a medication already prescribed to some patients with MS—significantly slows disability progression in people ...
May 28, 2026
0
6
Cannabis is a psychoactive drug derived from the Cannabis sativa plant. Users can smoke the dried flowers and leaves as marijuana or make them into an oil or resin.
May 27, 2026
0
9
At age 49, Jan Janisch-Hanzlik's multiple sclerosis was destroying her freedom to live the life she wanted. She gave up her active nursing job for a desk role. Frequent falls made her afraid to carry her grandchildren. She ...
May 26, 2026
0
2147
Researcher Daan van der Vliet, together with colleagues from the Netherlands Institute for Neuroscience, Leiden University, and Utrecht University, has discovered an important mechanism that may be linked to severe progression ...
May 22, 2026
0
9
A new study offers clues as to why exercise can improve neurological symptoms in people with multiple sclerosis (MS). The study, led by investigators from Mass General Brigham and University Medical Center Hamburg-Eppendorf ...
May 21, 2026
0
16
Using psychoactive substances for recreation, socialization or symptom self-management is common for many people living with multiple sclerosis. When used to self-manage symptoms, some psychoactive substances may provide ...
May 19, 2026
0
6
The U.S. Food and Drug Administration has approved a label expansion for Vyvgart (efgartigimod alfa-fcab) and Vyvgart Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) for the treatment of adult patients with (gMG). The ...
May 18, 2026
0
7
